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Abstract 
Transport of inorganic phosphate (Pi) across the plasma membrane is essential for normal 
cellular function. Members of two families of SLC proteins (SLC20 and SLC34) act as Na+-
dependent, secondary-active cotransporters to transport Pi across cell membranes. The SLC34 
proteins are expressed in specific organs important for Pi homeostasis: NaPi-IIa (SLC34A1) 
and NaPi-IIc (SLC34A3) fulfill essential roles in Pi reabsorption in the kidney proximal 
tubule and NaPi-IIb (SLC34A2) mediates Pi absorption in the gut. The SLC20 proteins, PiT-1 
(SLC20A1), PiT-2 (SLC20A2) are expressed ubiquitously in all tissues and although 
generally considered as “housekeeping” transport proteins, the discovery of tissue-specific 
activity,regulatory pathways and gene-related pathophysiologies, is redefining their 
importance. This review summarises our current knowledge of SLC20 and SLC34 proteins in 
terms of their basic molecular characteristics, physiological roles, known pathophysiologies 
and pharmacology. 
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1. Introduction 
 In mammals, phosphorus is an essential element for cellular signaling, metabolic and 
synthetic pathways as well as fulfilling a necessary structural role in bone and phospholipid 
membranes. It is obtained from the diet as anionic inorganic phosphate (Pi) and requires 
active transport to traverse the cell membrane. Moreover, transepithelial transport of Pi in 
different epithelia (specifically in kidney and small intestine) contributes fundamentally to 
overall Pi homeostasis (Fig 1A). This is particularly evident in kidney where Pi reabsorption 
in the proximal tubule is regulated by a number of hormones and metabolic factors thereby 
adusting excretion of Pi according to the organism’s Pi requirements. Any defects in the 
regulation of cotransporter proteins or the expression of mutated proteins can lead to severe 
pathophysiological conditions. Two genetically distinct families of sodium-coupled 
cotransporters mediate transport of Pi in mammals: SLC20 comprising SLC20A1 (PiT1), 
SLC20A2 (PiT2) and SLC34 comprising SLC34A1 (NaPi-IIa), SLC34A2 (NaPi-IIb) and 
SLC34A3 (NaPi-IIc) (see Tables 1, 2). Whereas the physiological roles of SLC34 proteins, 
with their well-defined tissue distribution, has been extensively investigated and 
characterized, the novel roles of the more ubiquitously expressed SLC20 proteins are only 
beginning to emerge in addition to that to which they were originally ascribed, as 
housekeeping proteins. 
2. The SLC34 family (type II Na+-coupled Pi transporters: NaPi-IIa, NaPi-IIb, NaPi-IIc) 
2.1 NaPi-IIa 
 NaPi-IIa (SLC34A1) was identified by functional expression cloning using X. laevis 
oocytes and rat and human kidney cDNA library (Magagnin et al., 1993). The major site of 
expression is the renal proximal tubule where the 80-90kDa protein is localized in the 
microvilli that form the brush border membrane (BBM). In human tissue, significant mRNA 
expression is detected only in the kidney (Fig 1B) (Nishimura and Naito, 2008). Under 
normal physiological conditions, the abundance of NaPi-IIa is highest in the S1 proximal 
tubule segments of juxtamedullary nephrons (Custer M, 1994). 
2.2 NaPi-IIb 
 NaPi-IIb (SLC34A2) was identified from a mouse embryo EST clone and was 
specifically localized to enterocytes of the small intestine (Hilfiker et al., 1998). In humans 
mRNA is detected in lungs, testis, salivary gland, thyroid gland, small intestine, liver, 
mammary gland, uterus but not in renal tissue (Fig 1B) (Nishimura and Naito, 2008).  
2.3 NaPi-IIc 
 NaPi-IIc (SLC34A3) was identified from human EST clones (Segawa et al., 2002). 
Expression of NaPi-IIc was found exclusively in the kidney and proposed to be growth related 
based on animal studies: in weaning rats it is expressed in the BBM of S1 segments of 
proximal tubules, but is strongly down-regulated in adult animals (Miyamoto et al.; Segawa et 
al., 2002). The 75kDa protein is localized at the apical membranes of proximal tubule 
epithelia of juxtamedullary nephrons (Segawa et al., 2002). Like NaPi-IIa, the distribution of 
mRNA in human tissue is also renal specific (Fig 1B) (Nishimura and Naito, 2008).  
 
2.4 Kinetics and structure-function relationships of SLC34 proteins 
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2.4.1 Kinetics of SLC34 proteins 
All 3 isoforms preferentially transport divalent Pi (Bacconi et al., 2005; Forster et al., 
1999) and are exclusively Na+-dependent, although Li+ ions (Andrini et al.) can partly replace 
Na+ to drive transport. The transport capacity of all SLC34 proteins is strongly dependent on 
pH, which defines the monovalent/divalent Pi distribution in the extracellular compartment 
and protons also directly modulate the transport kinetics e.g.(Forster et al., 2000). At pH 7.4, 
the 3 isoforms display similar apparent substrate affinities of approximately 100 µM and 40 
mM for divalent Pi and Na
+ respectively. Functionally, they can be distinguished as 
electrogenic (NaPi-IIa,b) and electroneutral (NaPi-IIc) cotransporters (Fig 2A). NaPi-IIa/b 
translocate one net positive charge per transport cycle and their transport rate is a function of 
membrane potential. They mediate transport with a 3:1 Na+:Pi stoichiometry (Forster et al., 
1999). The transport kinetics of NaPi-IIc are insensitive to membrane potential, no net charge 
is translocated and transport is mediated with a 2:1 stoichiometry (Bacconi et al., 2005; 
Segawa et al., 2002). The stoichiometry difference means that the theoretical Pi concentrating 
capacity is approximately 100-fold higher for NaPi-IIa/b, at the cost of a 10-fold greater 
inward flux of Na+ ions compared to NaPi-IIc, together with net charge movement, both of 
which must be compensated by the cell through the action of the Na+/K+-ATPase. 
Kinetic studies have established that for NaPi-IIa/b, 2 Na+ ions bind sequentially and 
cooperatively before Pi (Virkki et al., 2006). A 3rd Na+ binding transition precedes a rate-
limiting reorientation of the fully loaded carrier. Li+ ions can compete for occupancy of the 
the 1st Na+ binding site (Andrini et al.).The order of release of substrates to the cytosol is 
unknown. For NaPi-IIc, the 1st Na+, which confers electrogenicity to NaPi-IIa/b, still interacts 
but is not cotransported (Ghezzi et al., 2009). Electrogenic SLC34 proteins exhibit an 
uncoupled leak that is most likely mediated by Na+ ions and is active only in the absence of Pi 
(Andrini et al., 2008). The Na+-leak is not found for the electroneutral NaPi-IIc (Bacconi et 
al., 2005), nevertheless, naturally occurring mutations in NaPi-IIc have been reported to result 
in a significant Na+-leak (Jaureguiberry et al., 2008).  
 
2.4.2 Structure-function relationships of SLC34 proteins. 
SLC34 proteins belong to a unique class of membrane proteins and share no homology 
with the other main transporter families, even at the bacterial level. The current lack of a 3-D 
structure of the mammalian SLC34 proteins or their bacterial homologs, means that structural 
information is based on indirect biophysical and biochemical studies on wild-type and 
engineered mutations, e.g.(Forster et al., 2002; Virkki et al., 2007). SLC34 proteins are all 
assumed to be functional monomers (Kohler et al., 2000), although indirect evidence suggests 
they may exist as dimers at the BBM (Forster et al., 2006; Gisler et al., 2007). The primary 
sequences of the mammalian isoforms vary from 599 amino acids (NaPi-IIc) to approximately 
640 amino acids (NaPi-IIa and NaPi-IIb), with differences mainly in the intracellular C-and 
N-terminal regions and the large extracellular linker region. This linker contains 2 N-
glycosylation sites and a disulfide bridge that links the two halves of the protein (Fig 2A).The 
currently proposed topology of the eukaryotic isoforms comprises 12 transmembrane domains 
(TMDs) (Fig 2). This model incorporates predictions from biochemical and biophysical 
studies including epitope labeling, cysteine scanning mutagenesis  and in vitro glycosylation 
assays (for review see: (Forster et al.; Forster et al., 2006; Forster et al., 2002; Virkki et al., 
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2007). The C-terminal region is important for targeting, hormonal regulation and protein-
protein interactions, for example the TRL motif in the C-terminal plays a role as a PDZ 
binding motif (Hernando et al., 2001; Karim-Jimenez et al., 2001), and a KR motif located in 
an intracellular linker region (Fig 2A) is critical for PTH sensitivity (Karim-Jimenez et al., 
2000). Sequence analysis reveals an inverted repeat motif that is conserved amongst SLC34 
isoforms and homologs in all phyla (Werner and Kinne, 2001). The repeat regions contain 
two opposed reentrant loops formed by pairs of discontinuous helices linked by a short 
peptide stretch; studies confirm their functional role in defining the transport (Forster et al., 
2002). Similar structural motifs are also found in the 3-D structures of transporters with 
known structure, e.g.(Forrest et al.; Screpanti and Hunte, 2007), which underscore their role in 
substrate coordination. All SLC34 proteins, including bacterial homologs, are expected to 
have similar functional core elements comprising TMDs2-10 (Fig. 2A). No information is 
available concerning the localization of the substrate coordination sites. The electroneutral 
NaPi-IIc (Segawa et al., 2002) provided an important tool to identify the molecular 
determinants of electrogenicity; in particular 3 critical amino acids essential for Na+ binding 
and charge translocation, conserved in all electrogenic isoforms, were identified by 
mutagenesis (Bacconi et al., 2005).  
 
2.5 Physiological, pathophysiological and pharmaceutical aspects of SLC34 proteins 
2.5.1 Physiological role and regulation 
 The expression of NaPi-IIa and NaPi-IIc is limited to the BBM of renal proximal 
tubules (Custer M, 1994; Segawa et al., 2002). Both transporters together with PiT-2 (see 
3.3.1) are responsible for the reabsorption of most of the Pi from the primary filtrate. 
However, their quantitative contribution is an open issue (e.g.(Villa-Bellosta and Sorribas)). 
NaPi-IIa seems to be the major transporter in murine kidneys, as mice deficient for this 
cotransporter are hypophosphatemic due to a major loss of Pi in urine (Beck et al., 1998). In 
contrast, urinary excretion and circulating levels of Pi are normal in NaPi-IIc
-/- animals 
(Segawa et al., 2009). Based on these findings it was assumed that NaPi-IIa has a major 
quantitative impact on renal reabsorption of Pi. However, recent data suggest that NaPi-IIc 
may play more important role in humans (see 2.5.2) (Bergwitz et al., 2006; Miyamoto et al.).  
 NaPi-IIb has a wider pattern of expression (Hilfiker et al., 1998; Nishimura and Naito, 
2008) and its constitutive depletion in mice is lethal (Shibasaki et al., 2009). It is the only 
SLC34 member present in intestinal microvilli. In mice, it is specifically located in the ileum 
(Radanovic et al., 2005), which is the intestinal segment of this species that exhibit a higher 
Na-dependent Pi cotransporter activity. Inducible depletion of NaPi-IIb in mice results in fecal 
loss of Pi, indicating that this protein is required for proper intestinal absorption of Pi 
(Sabbagh et al., 2009). However, the mutant mice are normophosphatemic due to a 
compensatory upregulation of NaPi-IIa that results in increased renal reabsorption. 
 The abundance of SLC34 proteins at the apical membrane of renal proximal tubules or 
intestinal microvilli is the main determinant of Pi transport capacity. Their abundance is 
controlled by metabolic factors (dietary Pi), vitamins (1,25 dihydroxy vitamin D3, 
1,25(OH)2D) and hormones , including parathyroid hormone (PTH), dopamine, fibroblast 
growth factor 23 (FGF-23) and its co-receptor Klotho  that regulate Pi homeostasis (for review 
see (Bergwitz and Juppner, 2010) and (Huang and Moe)). With few exceptions, factors that 
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potentiate Pi retention, such as low Pi -dietary intake or 1,25(OH)2D, lead to an increased 
expression of either all or some of these transporters. In contrast, factors that signal Pi loss, 
including PTH, dopamine or FGF-23, associate with reduced abundance of SLC34 proteins. 
Neither short term up- or down-regulation seems to involve changes on mRNA levels, 
suggesting a posttranscriptional control. The nature of this posttranscriptional mechanism has 
been clarified in the case of the PTH-induced downregulation of NaPi-IIa: PTH 
administration leads to phosphorylation of NHERF1, an adaptor protein that contributes to 
stabilize NaPi-IIa at the proximal BBM; phosphorylation of NHERF1 decreases its affinity 
for NaPi-IIa, resulting in a reduced stability and therefore removal of the cotransporter from 
the apical membrane  (Deliot et al., 2005; Weinman et al., 2007). Whether or not similar 
protein-protein interaction mechanisms contribute to stabilize the membrane expression of 
NaPi-IIc and /or NaPi-IIb is unknown. K-deficiency and soluble Klotho are among the 
phosphaturic factors that do not act by reducing the expression of NaPi-IIa. Instead, K-
deficiency in rats associates with higher NaPi-IIa (but reduced NaPi-IIc and PiT2); an altered 
lipid composition of the BBM has been postulated to inhibit NaPi-IIa activity in this 
metabolic situation (Breusegem et al., 2009; Zajicek et al., 2001). Soluble klotho has a 
phosphaturic effect independent of FGF23 that manifest prior to the reduction of NaPi-IIa 
abundance in BBM (Hu et al.); the precise mechanism remains unknown, although it appears 
to involve glycosylation of an unidentified factor (for review see (Huang and Moe)). 
 
2.5.2 Pathophysiology and effect of naturally occurring mutations 
 Failure to maintain circulating levels of Pi constant results in pathological states 
associated with both hyper- and hypo-phosphatemia (for review see (Bergwitz and Juppner, 
2010). Several heterozygous mutations of NaPi-IIa were reported in patients with 
nephrolithiasis and osteoporosis (Prie et al., 2002), but were not confirmed in vitro studies 
(Virkki et al., 2003). In addition, mutations of NaPi-IIa were identified in patients with 
autosomal recessive Fanconi syndrome and hypophosphatemic rickets (Magen et al.; Magen 
et al.), as well as in Sotos’ patients exhibiting nephrocalcinosis and hypercalcemia but normal 
circulating Pi (Kenny et al.). In contrast, there is a large number of reported mutations of 
NaPi-IIc in patients with hypophosphatemic rickets with hypercalciuria (HHRH), e.g. 
(Bergwitz et al., 2006). These findings have challenged the assumption of NaPi-IIa being the 
major Pi-reabsorbing protein in the human kidney. For NaPi-IIb, several reports indicate that 
mutations of this transporter lead to alveolar and testicular microlithiasis ((Corut et al., 2006), 
for review see (Miyamoto et al.). 
 
2.5.3 Pharmacology 
Interest in inhibitors for SLC34 proteins focuses on blockers for NaPi-IIb as a means 
to reduce intestinal Pi absorption in chronic kidney disease. Transport by all SLC34 isoforms 
is blocked by the competitive inhibitor phosphonoformic acid or foscarnet (PFA) (Loghman-
Adham, 1996). However, PFA has a high inhibition constant ( ~0.4-0.6 mM (e.g.(Villa-
Bellosta and Sorribas, 2009) compared with the Pi apparent affinity and shows nephrotoxic 
effects. These features make it unattractive to limit dietary Pi absorption as a strategy to 
prevent hyperphosphatemia in cases where kidney function is compromised (Wallin and 
Ryrfeldt, 1995). Other pharmacologically interesting compounds with significantly lower 
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inhibition constants than PFA have been the subject of commercial studies (Weinstock, 2004). 
These possibly act in a non-competitive manner on NaPi-II proteins as reported for the 
compound JTP-59557 (Matsuo et al., 2005). A phosphophloretin compound was reported to 
exhibit inhibition at micromolar concentrations (Peerce et al., 2003) although its efficacy on 
heterologously expressed SLC34 proteins is unknown.  
 
3. The SLC20 family (Type III Na+-coupled Pi cotransporters, PiT-1, PiT-2) 
3.1 PiT-1, PiT-2 
 The two known mammalian isoforms of SLC20 proteins (PiT-1, SLC20A1, and PiT-2, 
SLC20A2) were originally identified as retroviral receptors Glvr-1 (gibbon ape leukemia 
virus receptor) and Ram-1 (rat amphotropic leukemia virus receptor), respectively. Their role 
as Na+-coupled Pi transporters was first reported in 1994 (Kavanaugh et al., 1994; Olah et al., 
1994).  
 The mRNAs for both SLC20 isoforms are ubiquitously expressed in mice, yet cell 
specific localization of SLC20 proteins in different organs is still largely unknown (Collins et 
al., 2004). This widespread expression pattern is also reflected at the mRNA level of human 
tissue (Fig 1B) (Nishimura and Naito, 2008). In kidney, expression of both PiT1 and PiT-2 
was detected, yet the cellular localization at the apical membrane of proximal tubular epithelia 
was described only for PiT-2 (Villa-Bellosta et al., 2009). In small intestine, expression both 
PiT-1 and PiT-2 has also been reported (Bai et al., 2000; Giral et al., 2009).  
 
3.2 Kinetics and structure-function relationships of SLC20 proteins 
3.2.1 Kinetics  
The role of SLC20 proteins as Na+-coupled Pi transporters was first confirmed by 
heterologous expression in X. Laevis oocytes and established that they were electrogenic and 
Na+-dependent (Kavanaugh and Kabat, 1996; Kavanaugh et al., 1994). From these and other 
studies (e.g. (Bai et al., 2000; Bottger et al., 2006; Olah et al., 1994)) it became apparent that 
SLC20 proteins were functionally distinct from SLC34 proteins. These differences were 
highlighted in a detailed characterization of PiT-1 transport kinetics (Ravera et al., 2007). The 
most important kinetic property that distinguishes SLC20 from SLC34 proteins is that the 
former preferentially transport monovalent Pi with a 2:1 Na
+:Pi stoichiometry (Fig 2B) 
(Ravera et al., 2007; Saliba et al., 2006). Like all SLC34 proteins investigated to date, 
apparent affinities for Pi and Na
+ are typically d100 µM and ~50 mM respectively. PiT-1 is 
significantly less sensitive to pH compared to SLC34 proteins, whereby the maximum 
transport rate is relatively constant over a 3 pH units and the apparent Pi affinity decreases 
only at pH <6. The preference for monovalent Pi and insensitivity of transport kinetics to 
reduced pH means that SLC20 proteins can provide Pi transport capacity under conditions 
where SLC34 proteins are functionally compromised. Unlike SLC34 proteins that are 
exclusively Na+ drive, for PiT-1, Li+ can fully replace Na+ as the driving cation, albeit with a 
significantly reduced transport rate (Ravera et al., 2007). Furthermore, in the absence of Na+, 
lowering pH from 7.5 to 6.0 induces significant Pi uptake in Xenopus oocytes that expressed 
PiT-2, which suggest that H+ may also substitute for Na+ for this isoform (Bottger et al., 2006; 
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Villa-Bellosta et al., 2007). Na+ is the first ion to interact followed by a random binding of 
Na+ and Pi (Ravera et al., 2007). Finally, unlike SLC34 proteins, in which the final 
translocation of substrates is assumed electroneutral, the equivalent partial reaction may 
confer electrogenicity to PiT-1,2 (Virkki et al., 2007). 
 
3.2.2 Structure-function relations. 
 The gene products of the SLC20 family belong to a unique class of proteins that are 
represented in all phyla (Bottger and Pedersen; Virkki et al., 2007). Compared with SLC34 
proteins, relatively few structure-function studies have been undertaken. The current topology 
(Fig 2B) is proposed to comprise 12 TMDs with extracellular N- and C-terminal tails. This 
topology is suggested by bioinformatic predictions, tagging, cysteine scanning and in vitro 
glycosylation studies, e.g.(Bottger and Pedersen; Farrell et al., 2009; Salaun et al., 2001). 
Studies have also focused on identifying the viral receptor domains, which has led to further 
insight into the SLC20 protein structure-function relations (Bottger and Pedersen, 2004; 
Feldman et al., 2004; Salaun et al., 2001). For example, the large intracellular domain and 
associated TMDs have been removed and shown not to be required for retroviral recognition 
(Bottger and Pedersen, 2004), although it is unknown if the transport function was 
compromised. PiT-1 and PiT-2 differ in the location of their virus binding sites: for PiT-2 this 
has been identified in the 1st extracellular loop (Feldman et al., 2004), whereas that for PiT-1 
has been suggested to be in the 4th extracellular loop (Johann et al., 1993) (Fig. 2B). Like 
SLC34, the structure of SLC20 proteins contains an inverted repeat architecture (Fig. 2B).  
3.3 Physiological, pathophysiological and pharmaceutical aspects of SLC20 proteins 
 
3.3.1 Physiological role and regulation 
 The ubiquitous expression of SLC20 protein at the mRNA level (Fig 1B) suggested 
they undertake  a “housekeeping” role throughout the mammalian organism, however recent 
studies are bringing to light a diversity of more specific physiological roles. For example, 
PiT1 may play an important role in bone Pi homeostasis and its abundance is regulated by 
several factors involved in bone metabolism, including IGF-1 or BMP2 (reviewed in (Forster 
et al.; Miyamoto et al.). Furthermore, a number of studies also suggest a role of PiT-1 in 
hyperphosphatemia induced calcification of blood vessels (Lau et al.; Shanahan et al.) as well 
as in parathyroid function (Tatsumi et al., 1998). Recently a new function of PiT-1, 
independent of its transport function, has emerged. Depletion of PiT-1 expression in HeLa 
cells resulted in reduced cell proliferation and impaired mitosis (Beck et al., 2009). In vivo 
studies underscored these findings by showing that a PiT-1 knockout mouse is embryonic 
lethal, reflecting the importance of PiT-1 in liver development (Beck et al.), anemia and 
arrested growth (Festing et al., 2009). 
 With respect to the main organs for Pi homeostasis (Fig 1), the small intestine and 
kidney, the relative contributions of PiT-1/2 are largely unknown. In both organs PiT-1/2 may 
contribute only moderately (~5%) to transepithelial Pi transport (Forster et al.; Villa-Bellosta 
and Sorribas). In kidney, the apical abundance of PiT-2 is regulated by dietary intake of Pi 
(Villa-Bellosta et al., 2009), potassium deficiency (Breusegem et al., 2009) and PTH (Picard 
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et al., 2010); its regulation by phosphatonins remains to be investigated. In small intestine, the 
abundance of PiT-1 protein is altered by dietary Pi (Giral et al., 2009).  
 
3.3.2 Pathophysiology and effect of naturally occurring mutations 
 Linkage analysis in a family with familial idiopathic basal ganglia calcification (Fahr 
disease) identified loss of function mutations in the SLC20A2 gene that represent the 
molecular basis for disturbed Pi homeostasis in the brain of these patients, implicating the 
involvement of PiT-2 in brain (Wang et al.) 
3.3.3 Pharmacology 
 PFA is a weak inhibitor of PiT-1,2 mediated transport activity (Villa-Bellosta et al., 
2007; Villa-Bellosta et al., 2009) and currently no specific inhibitors for SLC20 have been 
reported. 
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Figure Legends 
 
Fig 1. 
A. The main organs involved in inorganic phosphate (Pi) homeostasis in man, indicating the 
principal sites of confirmed protein expression of members of the SLC20 and SLC34 families. 
Normally, dietary Pi input is balanced by excretion in feces and urine to maintain a reasonable 
stable circulating Pi pool. The kidney plays a crucial role in this balance by reabsorbing Pi 
from the glomerular filtrate. 
B. The distribution of SLC34 (upper panel) and SLC20 (lower panel) at the mRNA level 
detected in human tissue. The high expression of both NaPi-IIa and NaPi-IIc in kidney, and 
NaPi-IIb in small intestine (indicated by arrows) is in stark comparison to the distribution of 
PiT-1, -2. NaPi-IIb mRNA is found in a number of other organs, but not the kidney. Data 
adapted from (Nishimura and Naito, 2008).  
 
Fig 2  
Cartoons illustrating the basic transport mechanism and molecular features of SLC34 (A) and 
SLC20 (B) proteins (adapted from (Ghezzi et al., 2009)). Topology models show the 
predicted transmembrane domains (numbered) and repeat regions (dark shading) for each 
protein family. The 3-D folding for proteins of both families is currently not known. 
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Tables 
 
 1. SLC34-Type II Na+-phosphate cotransporter family 
Human 
gene 
name 
Protein 
name 
Aliases Predominant 
substrates 
Transport 
type/coupling 
ions* 
Tissue distribution 
and 
cellular/subcellula
r expression 
Link to disease# Human 
gene locus 
Sequence 
accession ID 
Splice 
variants 
and their 
features 
SLC34A1 NaPi-IIa Napi-3, NPT2, 
npt2 
Inorganic 
phosphate 
(divalent) 
C/Na/HPO42- Kidney (proximal 
tubule, apical 
membrane), 
osteoclasts, 
neurons 
G/XLH, G/ADHR, A/OHO, 
nephrocalciosis.hypo-
phosphatemia, urolithiasis, 
osteoporosis 
5q35 NM003052.4  
SLC34A2 NaPi-IIb  Inorganic 
phosphate 
(divalent) 
C/Na/HPO42- Small intestine, 
lung, testis, liver, 
secreting 
mammary gland 
Pulmonary alveolar 
microlithiasis, testicular 
microlithiasis 
4p15 NM006424.2  
SLC34A3 NaPi-IIc  Inorganic 
phosphate 
(divalent) 
C/Na/HPO42- Kidney (proximal 
tubule, apical 
membrane) 
Hypophosphatemic rickets 
with hypercalciuria 
9q34 NM080877.2  
* C: cotransporter; E: exchanger; F: facilitated transporter; O: orphan transporter    # A: acquired defect; G: genetic defect; P:pseudogene 
 
2. SLC20-Type III Na+-phosphate cotransporter family 
Human 
gene 
name 
Protein 
name 
Aliases Predominant 
substrates 
Transport 
type/coupling 
ions* 
Tissue distribution 
and 
cellular/subcellular 
expression 
Link to disease# Human 
gene locus 
Sequence 
accession ID 
Splice 
variants 
and their 
features 
SLC20A1 PiT-1 Gibbon ape 
leukemia virus 
receptor 1, 
GLVR1, Glvr1, 
FLJ41426, 
DKFZp686J2397 
Inorganic 
phosphate 
(monovalent) 
C/Na/H2PO4- Widely expressed  2q11-q14 NM005415  
SLC20A2 PiT-2 Amphotropic 
murine leukemia 
virus receptor 2, 
GLVR2, Glvr-2, 
MLVAR 
Inorganic 
phosphate 
(monovalent) 
C/Na/H2PO4- Widely expressed; 
kidney (proximal 
tubule, apical 
membrane) 
G/Idiopathic basal ganglia 
calcification 
8p12-p11 NM006749  
* C: cotransporter; E: exchanger; F: facilitated transporter; O: orphan transporter    # A: acquired defect; G: genetic defect; P:pseudogene 
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